Showing results (41-50 of 1,287) with videos related to

Sort By:
Pageof 129
The Journal of Experimental Medicine|September 1, 1988
Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formationR L Griffith, G T Virella, H C Stevenson, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|September 1, 1991
Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodiesM F Lopes-Virella, R L Griffith, K A Shunk, et al.
Diabetologia|November 19, 2002
Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathyD H Atchley, M F Lopes-Virella, D Zheng, et al.
Diabetes|June 24, 2000
Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetesM A Mironova, R L Klein, G T Virella, et al.
International Journal of Clinical & Laboratory Research|January 1, 1993
Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteersG Virella, I Virella, R B Leman, et al.
Metabolism: Clinical and Experimental|February 15, 2001
Effect of inflammatory cytokines on the metabolism of low-density lipoproteins by human vascular endothelial cellsR L Klein, J L Ascenção, M Mironova, et al.
Atherosclerosis|January 16, 1998
The uptake of LDL-IC by human macrophages: predominant involvement of the Fc gamma RI receptorM F Lopes-Virella, N Binzafar, S Rackley, et al.
Cancer|May 1, 1977
Asynchronous development of two monoclonal proteins (IgM lambda and delta 1 chains) in a patient with abdominal lymphomaG Virella, J M Monteiro, M F Lopes-Virella, et al.
Diabetologia|December 1, 1987
Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from type 1 (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoproteinsT J Lyons, R L Klein, J W Baynes, et al.
Diabetes|June 1, 1996
LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidationA J Jenkins, R L Klein, C N Chassereau, et al.
Pageof 129